Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about orforglipron as a potential treatment for adults with obesity or overweight, regulatory submission and action timing, and the timeline for future readouts, presentations, and other milestones relating to orforglipron and its clinical trials and reflects Lilly's current beliefs and expectations
S., Kuo, Y
GLP-1(2836) increases the levels of the sAC substrate ATP
Journal of Child Neurology , 28 , 12331237
US$ 23.57
US$ 27.70
US$ 27.29
US$ 22.14
US$ 29.46
US$ 26.47
US$ 26.68
US$ 26.26
US$ 28.11
US$ 24.86
US$ 23.63
